BIOTECH: DEL MAR –
TABLE OF CONTENTS
LENZ Therapeutics, a publicly traded biopharmaceutical firm helping millions of people improve their vision, has received a $30 million private investment from Ridgeback Capital.
Read latest San Diego Business Journal online.
Online newspapers
at PressDisplay.